Sequential combination therapies for HBeAg-positive chronic hepatitis B: the search continues Ankur JindalManoj Kumar Editorial 16 January 2021 Pages: 1 - 3
Is it time to spit? More evidence for the oral–gut–liver axis in liver disease Chathur AcharyaJasmohan S. Bajaj Editorial 21 January 2021 Pages: 4 - 5
Management of primary sclerosing cholangitis and its complications: an algorithmic approach Michal ProkopičUlrich Beuers Review Article Open access 30 December 2020 Pages: 6 - 20
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Yana GengKlaas Nico FaberHan Moshage Review Article Open access 06 February 2021 Pages: 21 - 35
Regression of portal hypertension: underlying mechanisms and therapeutic strategies Sonia SeliceanCong WangJordi Gracia-Sancho Review Article Open access 05 February 2021 Pages: 36 - 50
Efficacy of peg-interferon–nucleoside analog sequential optimization therapy in HBeAg-positive patients with CHB Wei XuQiang LiLiang Chen Original Article 29 September 2020 Pages: 51 - 59
Liver damage favors the eliminations of HBV integration and clonal hepatocytes in chronic hepatitis B Gang HuMing X. HuangXiao M. Peng Original Article Open access 03 February 2021 Pages: 60 - 70
Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients Matt LiuTai-Chung TsengMindie H. Nguyen Original Article 04 January 2021 Pages: 71 - 81
Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy Xiaoning WuJialing ZhouJidong Jia Original Article 18 January 2021 Pages: 82 - 92
Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child–Pugh B cirrhosis Jean-Frédéric BlancFaiza Khemissafor the PRODIGE 21 collaborators Original Article 09 January 2021 Pages: 93 - 104
One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment Tai-Chung TsengJonggi ChoiJia-Horng Kao Original Article 05 February 2021 Pages: 105 - 113
S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma Lu-Nan QiLiang MaLe-Qun Li Original Article 25 January 2021 Pages: 114 - 126
Prevalence of nonalcoholic fatty liver disease in mental disorder inpatients in China: an observational study Qiuyue MaFude YangMin Liu Original Article Open access 29 January 2021 Pages: 127 - 136
Sorafenib for advanced hepatocellular carcinoma provides better prognosis after liver transplantation than without liver transplantation Soon Kyu LeeJeong Won JangSeung Kew Yoon Original Article 26 January 2021 Pages: 137 - 145
Acute liver failure in Budd–Chiari syndrome and a model to predict mortality Paul J. ThuluvathJoseph J. AlukalTalan Zhang Original Article 02 January 2021 Pages: 146 - 154
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis Xin ZengXia ShengWei-Fen Xie Original Article 01 January 2021 Pages: 155 - 165
GATA6 modulates the ductular reaction to bile duct ligation Marjut PihlajokiTea SoiniDavid B. Wilson Original Article 24 January 2021 Pages: 166 - 178
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan Fu-Shun YenJames Cheng-Chung WeiChih-Cheng Hsu Original Article 10 January 2021 Pages: 179 - 190
Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis Y. LapidotA. AmirM. Safran Original Article 19 September 2020 Pages: 191 - 201
Implications of liver injury in risk-stratification and management of patients with COVID-19 Jiaofang ShaoYuan LiangLing Lu Original Article 06 February 2021 Pages: 202 - 212
Reductions in liver cirrhosis hospitalizations during the COVID-19 pandemic Jianglei LiDeliang LiuYuyong Tan Letter to the Editor 09 January 2021 Pages: 213 - 214
How can we reduce the impact of COVID-19 pandemic on timely access to liver transplantation in children? Mettu Srinivas ReddyJagadeesh MenonMohamed Rela Letter to the Editor 27 January 2021 Pages: 215 - 216
Chronic liver disease independently associated with COVID-19 severity: evidence based on adjusted effect estimates Haiyan YangJie XuYadong Wang Letter to the Editor 28 January 2021 Pages: 217 - 222